MedTrace Logo

Impact of Infant Formula on Caregiver-perceived Intolerance

NCT03679234 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2020-06-09

No results posted yet for this study

Summary

Understand the impact of switching to a commercially available infant formula on gastrointestinal symptoms

Conditions

  • Healthy Infants

Interventions

OTHER

Routine infant formula

Routine infant formula with probiotic

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Ryan Carvalho, MD · Nestle Nutrition

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Days
Max Age
60 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-24
Primary Completion
2019-04-01
Completion
2019-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03679234 on ClinicalTrials.gov